Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sibylle C Mellinghoff

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Molecular Therapy. Methods & Clinical Development|November 17, 2021
Digital PCR to quantify ChAdOx1 nCoV-19 copies in blood and tissuesAnita Badbaran, Reiner K Mailer, Christine Dahlke, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
Nivolumab induces long-term remission in a patient with fusariosisElham Khatamzas, Sibylle C Mellinghoff, Martin Thelen, et al.
Leukemia|February 1, 2019
Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL)Georg Maschmeyer, Julien De Greef, Sibylle C Mellinghoff, et al.
Frontiers in Immunology|January 6, 2022
Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19Sibylle C Mellinghoff, Kanika Vanshylla, Christine Dahlke, et al.
Emerging Infectious Diseases|June 22, 2019
Candida auris in Germany and Previous Exposure to Foreign HealthcareAxel Hamprecht, Amelia E Barber, Sibylle C Mellinghoff, et al.
European Journal of Cancer (Oxford, England : 1990)|January 13, 2023
Corrigendum to 'Nivolumab induces long-term remission in a patient with fusariosis' [Eur J Cancer 173 (2022) 91-94]Elham Khatamzas, Sibylle C Mellinghoff, Martin Thelen, et al.
Mycoses|January 12, 2018
EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia ManagementSibylle C Mellinghoff, Martin Hoenigl, Philipp Koehler, et al.
The Journal of Antimicrobial Chemotherapy|February 17, 2019
Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematologyPhilipp Koehler, Sibylle C Mellinghoff, Katrien Lagrou, et al.
Blood Research|March 28, 2025
Seroprevalence of SARS-CoV-2 antibodies in patients with hematological and oncological diseases in early 2024Louise M Cremer, Jannik Stemler, Rosanne Sprute, et al.
Blood Cancer Journal|May 31, 2022
Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic reviewVanessa Piechotta, Sibylle C Mellinghoff, Caroline Hirsch, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Molecular Therapy. Methods & Clinical Development|November 17, 2021
Digital PCR to quantify ChAdOx1 nCoV-19 copies in blood and tissuesAnita Badbaran, Reiner K Mailer, Christine Dahlke, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
Nivolumab induces long-term remission in a patient with fusariosisElham Khatamzas, Sibylle C Mellinghoff, Martin Thelen, et al.
Leukemia|February 1, 2019
Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL)Georg Maschmeyer, Julien De Greef, Sibylle C Mellinghoff, et al.
Frontiers in Immunology|January 6, 2022
Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19Sibylle C Mellinghoff, Kanika Vanshylla, Christine Dahlke, et al.
Emerging Infectious Diseases|June 22, 2019
Candida auris in Germany and Previous Exposure to Foreign HealthcareAxel Hamprecht, Amelia E Barber, Sibylle C Mellinghoff, et al.
European Journal of Cancer (Oxford, England : 1990)|January 13, 2023
Corrigendum to 'Nivolumab induces long-term remission in a patient with fusariosis' [Eur J Cancer 173 (2022) 91-94]Elham Khatamzas, Sibylle C Mellinghoff, Martin Thelen, et al.
Mycoses|January 12, 2018
EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia ManagementSibylle C Mellinghoff, Martin Hoenigl, Philipp Koehler, et al.
The Journal of Antimicrobial Chemotherapy|February 17, 2019
Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematologyPhilipp Koehler, Sibylle C Mellinghoff, Katrien Lagrou, et al.
Blood Research|March 28, 2025
Seroprevalence of SARS-CoV-2 antibodies in patients with hematological and oncological diseases in early 2024Louise M Cremer, Jannik Stemler, Rosanne Sprute, et al.
Blood Cancer Journal|May 31, 2022
Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic reviewVanessa Piechotta, Sibylle C Mellinghoff, Caroline Hirsch, et al.
Pageof 8